MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Soleno Therapeutics ROE Ratio 2011-2026 | SLNO
Annual ROE Ratio Soleno Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.64 | -71.74 | -24.75 | -232.58 | -173.72 | -54.1 | -205.89 | -43.85 | -59.04 | -351.22 | -493.47 | 134.28 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 134.28 | -493.47 | -130.95 |
Quarterly ROE Ratio Soleno Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -44.49 | -78.7 | -84.52 | -51.65 | -98.43 | -116.26 | -176.68 | -431.61 | -471.96 | -465.52 | -430.43 | -95.09 | -135.38 | -135.33 | -142.26 | -104.17 | -122.93 | -101.4 | -77.57 | -47.83 | -41.89 | -17.18 | -67.92 | -108.04 | -117.04 | -131.98 | -88.23 | -44.71 | -58.83 | -63.95 | -55.7 | -39.96 | -120.01 | -185.95 | -273.27 | -275.17 | -377.34 | -399.45 | -238.82 | -405.31 | -287.0 | -66.53 | -6.59 | 354.91 | 359.11 | 245.0 | 126.7 | 4.2 | 4.2 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 359.11 | -471.96 | -118.14 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 114.87 | -0.65 % | $ 34.9 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.63 | -1.21 % | $ 2.17 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.7 | -1.12 % | $ 686 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 21.91 | 0.27 % | $ 1.17 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.3 | -1.92 % | $ 463 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 166.79 | -2.59 % | $ 8.27 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 83.09 | -6.11 % | $ 10.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 27.12 | -1.53 % | $ 20 B |  Niderland |
 |
Illumina
ILMN
|
-51.54 | $ 126.92 | -1.24 % | $ 20.2 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.93 | - | $ 8.54 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 83.55 | -0.67 % | $ 5.64 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Medpace Holdings
MEDP
|
98.27 | $ 409.65 | -2.78 % | $ 11.8 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.19 | 0.46 % | $ 5.03 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 102.49 | -0.7 % | $ 8.45 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 259.57 | -1.47 % | $ 21.6 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 9.02 | 4.76 % | $ 1.16 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 120.07 | -4.46 % | $ 5.61 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.34 | -1.16 % | $ 2.03 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 16.84 | -1.58 % | $ 377 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.84 | 0.21 % | $ 448 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 200.17 | -2.06 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 195.05 | -0.8 % | $ 21.7 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Precipio
PRPO
|
-2.49 | $ 31.75 | 3.42 % | $ 51 M | USA |
 |
Personalis
PSNL
|
-40.05 | $ 5.5 | -7.72 % | $ 326 M | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 7.18 | -1.24 % | $ 300 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.65 | -12.64 % | $ 179 M | China |